By Bertram K. Two days after his death in May, Zach Sobiech’s song “Clouds” became the number one download on iTunes and now has surpassed seven million views on YouTube....

Late last year researchers with support from the Chordoma Foundation identified a genetic marker associated with that rare form of bone cancer. The Chordoma Foundation has also partnered with 23andMe...

February 28 is Rare Disease Day – a concept first initiated by the European Rare Disease Organization (EURORDIS) and now recognized around the world. Around 6,800 rare diseases have been...

Each person who has joined 23andMe’s Sarcoma research community has their own reasons for participating, but they all share the same hopes that we have – to find the causes...

The American Society of Clinical Oncology recently wrapped up its annual meeting, bringing together health care professionals focused on the fight against cancer. The five days were packed with mind-expanding...

Starting today cancer researchers will be gathering in Chicago at the meeting of the American Society of Clinical Oncology. Researchers and doctors at the annual meeting – the world’s largest...

By Meghan Mullins Before joining 23andMe, I worked at a more traditional genetic research lab. Like virtually all research centers, we didn’t return genetic results to our research participants. I...

23andMe is passionate about fighting cancer. We recently launched a Cancer Family History survey and within two months more than 20,000 customers have answered! We're already learning some very interesting things -- read on.

Cancer is not one disease, but many, and this has been one of the most challenging aspects of researching cures for cancer. 23andMe is applying its unique research platform to study cancer with research communities focused on sarcoma, myeloproliferative neoplasms, and metastatic breast cancer. Patients from all over the world can contribute directly to research and connect with others who have their disease, all while learning more about themselves.

Sarcoma is a rare form of cancer that is often caused by two genes fusing together but which two genes are involved can be different between different types of sarcoma. A group of French researchers recently discovered a new gene fusion characterizing a type of "Ewing-like" sarcomas.